Absorb bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD-ABSORB studies.

Giuseppe TarantiniGiulia MasieroAlberto BarioliValeria ParadiesGeorgios VlachojannisPaola TellaroliBernardo Cortese Bernardo Cortese Attilio VarricchioAlfonso IelasiBruno LoiGiuseppe SteffeninoDaisuke UeshimaMarco MojoliPieter Smits

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)

In this propensity-matched analysis pooling SVD patients of three large prospective studies, incidence of composite device-related events was comparable between BVS and EES up to 2 years follow-up. However, higher rates of stent thrombosis were found in the BVS group.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
risk factors
pulmonary embolism
prognostic factors
patient reported outcomes